Dublin, Feb. 06, 2019 (GLOBE NEWSWIRE) -- The "Implantable Biomaterials - Global Market Outlook (2017-2026)" report has been added to ResearchAndMarkets.com's offering.

Global Implantable Biomaterials market accounted for $96.11 billion in 2017 and is expected to reach $195.47 billion by 2026 growing at a CAGR of 8.2%.

Factors such as growing geriatric inhabitants worldwide, growing incidences of diseases and graft transplant surgeries, medical implants and technological advancements will drive the market growth. However, adverse reactions to biomaterials and strict regulatory requirements are some of the factors hampering the market growth.

A biomaterial is any substance of metallic, polymer, ceramic or natural origin that is suitable for introducing into living tissue as an implant without adversely affecting the patient. The selection of biomaterial is dependent on the application and properties of materials. Biomaterials are used to develop and manufacture implantable medical devices and grafts in many medical conditions.

Based on application, orthopedic segment is projected to grow due to growing degenerative bone diseases like osteoporosis and osteoarthritis, rising demand for minimally invasive surgeries and increase in accidents and sports injuries are factors favouring the market growth. In terms of geography, North America holds the largest market revenue due to rise in new products and the development of new biomaterials for ophthalmology, tissue engineering, plastic surgery and wound healing are fuel the market growth in this region.

What our report offers:

• Market share assessments for the regional and country level segments
• Market share analysis of the top industry players
• Strategic recommendations for the new entrants
• Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Key Topics Covered:

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.5 Research Sources

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Implantable Biomaterials Market, By Material
5.1 Introduction
5.2 Natural
5.3 Ceramics
5.4 Polymers
5.5 Metallic

6 Global Implantable Biomaterials Market, By Application
6.1 Introduction
6.2 Dental
6.3 Cardiovascular
6.4 Ophthalmology
6.5 Orthopedic
6.6 Other Applications

7 Global Implantable Biomaterials Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 E. I. Du Pont De Nemours And Company
9.2 BASF SE
9.3 3M
9.4 Evonik Industries Ag
9.5 Advansource Biomaterials Corporation
9.6 Royal Dsm
9.7 Corbion Purac
9.8 Collagen Matrix, Inc.
9.9 Celanese Corporation
9.10 Biomet, Inc.
9.11 Invibio, Inc.
9.12 Orthofix Holdings, Inc.
9.13 Stryker Corporation
9.14 Kls Martin And Medtronic.
9.15 Arthrex
9.16 Aap Implantate Ag
9.17 Zimmer Biomet Holdings, Inc.
9.18 Cam Bioceramics BV

For more information about this report visit https://www.researchandmarkets.com/research/5qbzp5/195_47_bn?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Biomaterials